Skip to content

Skin pH and pruritus

Skin pH and pruritus - SKIP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012743
Enrollment
40
Registered
2017-07-13
Start date
2017-07-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

only Healthy subjects

Interventions

Group 1: Provocation with cowhage and histamine after 28-day application of a low pH (pH4) cream on one arm of the subject. Determination of itch intensity (visual analogue scale) and skin pH at day 0

Sponsors

Charité Campus Charité Mitte
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult subjects Subjects must be able to communicate with the investigator. They must be able to understand the contents of the study and consent to participate in the study An existing health insurance (so that potential biopsy-related complications can be taken care of)

Exclusion criteria

Exclusion criteria: Current or previous treatment with immunosuppressants (e.g., prednisolone, ciclosporin A, methotrexate, dapsone or others) 4 weeks or 5 half-lives, whichever is longer, before the start of the study. Intake of antihistamines 5 days and leukotriene antagonists 7 days before study Significant disease through which the subject could have a weakened immune system Presence of a skin disease or of chronic pruritus Pregnant or lactating women In the history, a hypersensitivity or allergy to local anesthetics (in subjects where a skin biopsy is taken). Taking blood thinning medications Allergies to local anesthetic

Design outcomes

Primary

MeasureTime frame
Comparison of the itch intensity (visual analogue scale) in the skin with reduced pH, normal pH (untreated skin) and increased pH (all on day 28).

Secondary

MeasureTime frame
Change of the skin pH on day 28 after daily application of a cream with low or high pH compared to the skin pH before treatment and on untreated skin on day 28. Immunohistological examinations are performed in some subjects (optional biopsy). These studies have no defined endpoints but are purely exploratory.

Countries

Germany

Contacts

Public ContactHesna Gözlükaya

Klinik für Dermatologie und Allergologie Charité - Universitätsmedizin Berlin

hesna.goezluekaya@charite.de+49 30 450 618296

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026